Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
20 results
D3.340 - The importance of de-labeling contrast allergy în cardiology department - clinical case
D3.341 - Alignment with International Anaphylaxis Management Guidelines in a Tertiary Referral Center in Central Asia: A Retrospective Clinical Audit
D3.342 - Adverse Events of Biologic Therapies: A One-Year Retrospective Study
D3.343 - Hereditary alpha-tryptasemia: clinical variability and anaphylaxis triggers in six genetically confirmed cases
D3.344 - Rapid Desensitization to Iohexol Following Iopamidol-Induced Anaphylaxis Prior to Urgent Coronary Angiography
D3.345 - Anaphylactic Shock: Clinical Analysis of 8 Cases with Post-Hospital Outpatient Follow-Up
D3.346 - From Anaphylaxis to Oral Allergy Syndrome: Multiple Seed Hypersensitivity in a Single Pediatric Patient
D3.347 - Idiopathic Anaphylaxis: A Diagnostic Challenge
D3.348 - Alpha‑gal Syndrome in Young People: A Call for Public Health Awareness in Tick‑Endemic Areas of Scotland and North East England
D3.349 - Takotsubo cardiomyopathy triggered by anaphylaxis after a honey bee sting, forming ATAK complex: a rare case report
D3.351 - A case of Kounis syndrome in idiopathic anaphylaxis and indolent systemic mastocytosis
D3.352 - Long-term analytical stability of ImmunoCAP tryptase supports enduring clinical interpretation thresholds
D3.353 - Clinical Characteristics and Triggers of Pediatric Anaphylaxis Cases: A Retrospective Single-Center Experience
D2.114 - Occupational asthma and rhinitis in a worker in the single-use food packaging industry: challenges of multi-agent exposure
D2.115 - Occupational asthma and rhinitis to isocyanates in industrial settings
D2.108 - Type 2 Inflammation Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps Under Treatment with Biologic Agents
D2.110 - Real-world evaluation of tezepelumab in patients with severe asthma and chronic rhinosinusitis in France: preliminary results from the ROSE retrospective study
D2.113 - Comparison of Non-Asthmatic Allergic Rhinitis Patients with Normal and Low FEF25–75 Levels
D2.120 - Missing the Red Flags? Identification of High-Risk Paediatric Asthma Admissions Following the 2024 BTS/NICE/SIGN Update
D2.121 - Seroprotection to influenza virus in vaccinated patients with bronchial asthma on biological treatment
Download the app
The congress at your fingertips
Available on
Download